Introduction {#Sec1}
============

Serotonin (5-HT) is an important neurotransmitter in the central nervous system. However, approximately 95% of total body 5-HT is present in the gastrointestinal (GI) tract. 5-HT has diverse roles in the GI tract which include regulating mucosal homeostasis, increasing motility, and modulating electrolyte transport^[@CR1]--[@CR7]^. Optimal levels of 5-HT are maintained via the serotonin transporter (SLC6A4, SERT) which actively imports 5-HT, allowing for its degradation by intracellular monoamine oxidases^[@CR8],[@CR9]^. Additionally, circulating platelets uptake 5-HT from the GI tract via SERT which allows distribution of gut-derived 5-HT to peripheral tissues where it regulates bone remodeling, coagulation, and energy metabolism^[@CR10]--[@CR12]^. Both blood plasma and platelets are depleted of 5-HT in SERT^−/−^ mice^[@CR1],[@CR13]^. In addition, most peripheral organs have significantly depleted 5-HT levels, confirming that their normal serotonin content is dependent upon SERT^[@CR1],[@CR14]--[@CR18]^. SERT^−/−^ mice, thus, exhibit a pleotropic phenotype which includes anxiety-like behavior, reduced bone density and strength, and GI abnormalities^[@CR19],[@CR20]^.

In addition to other observed abnormalities, there is a metabolic phenotype similar to Type-2 diabetes (T2D) that develops in SERT^−/−^ mice as they reach adulthood^[@CR19],[@CR21],[@CR22]^. At 3 months of age, there is no significant difference in body weight in SERT^−/−^ vs. SERT^+/+^ mice, but an increase in visceral adiposity with a decrease in brown adipose tissue is observed in SERT^−/−^ mice^[@CR21]^. Additionally, SERT^−/−^ mice exhibit many metabolic disturbances at this age including hyperinsulinemia, hyperleptinemia, and insulin resistance, prior to any measurable weight gain^[@CR22]^. These effects are independent of food consumption, but a decrease in locomotor activity has not been definitively ruled out as a possible cause^[@CR19],[@CR21],[@CR22]^. Selective serotonin reuptake inhibitors (SSRIs) are pharmacological agents which inhibit SERT function that are used to treat depression and other psychiatric disorders. In accordance with the metabolic phenotype in SERT^−/−^ mice, patients taking SSRIs exhibit weight gain and an increased risk of developing T2D^[@CR23]^. Therefore, it is critical to enhance our understanding of how decreased SERT function is linked to metabolic disorders.

Increasing evidence implicates the role of the gut microbiome, which refers to the functional network of microbes that reside inside the gut, in regulating normal host physiology as well as pathophysiology. For example, gut microbes secrete various molecules, breakdown non-digestible macromolecules, and stimulate the immune system^[@CR24]^. As the gut microbiota reside at the interface of ingested nutrients and the host, it is not surprising that many studies have linked changes in gut microbiome to metabolic syndrome. For example, administration of broad spectrum antibiotics to obese mice ameliorate glucose intolerance independent of food intake or adiposity^[@CR25]^. In both mouse-models of metabolic syndrome and patients with T2D, the abundances of *Akkermansia muciniphila* and *Bifidobacteria* are decreased^[@CR26]^. These bacteria are thought to protect against leakage of bacterial products from gut bacteria into the bloodstream as a result of increased intestinal permeability, a proposed mechanism by which gut microbiota contribute to the development of metabolic syndrome^[@CR26]^.

While it is known that gut bacteria are able to influence host serotonergic machinery^[@CR27]--[@CR30]^, the effect of changes in host serotonergic signaling on intestinal microbiome homeostasis has not been investigated in mice. We hypothesized that SERT deletion in mice is associated with changes in the composition and function of bacteria in the intestine. Utilizing the fecal and cecal stool samples from global SERT^−/−^ mice and SERT^+/+^ littermates, we analyzed the impact of SERT deficiency on the intestinal microbiome. Our results show that deletion of SERT in mice causes dysbiosis. Further, we found that bacterial community structure is disrupted, and metabolic capabilities of the microbiome are altered in SERT^−/−^ mice. Based upon our findings from our previous microarray analysis comparing gene expression in the ileal mucosa of SERT^+/+^ and SERT^−/−^ mice (GEO accession GSE93534), we correlated host expression of enzymes involved in lipid metabolism with changes in gut microbiome^[@CR31]^. Indeed, expression of these enzymes correlated with changes in gut bacterial metabolism of unsaturated fatty acids. These studies enlighten our understanding of how dysregulation of the host serotonergic system can have a significant impact on the intestinal microbiome, which in-turn likely impacts overall host physiology.

Results {#Sec2}
=======

β-diversity, but not α-diversity, is altered by SERT deficiency {#Sec3}
---------------------------------------------------------------

To assess differences in the ecological structure of the bacterial populations in each mouse's cecal and fecal isolates between SERT^−/−^ and SERT^+/+^ mice, α- and β- diversity were determined. There was no significant difference (*p* \> 0.05, Two-way ANOVA) in the α-diversity of SERT^−/−^ mice as compared to SERT^+/+^ littermates as calculated by rarefaction curve and Shannon diversity index (Fig. [1A,B](#Fig1){ref-type="fig"}). β-diversity was significantly different (*p* \< 0.05, PERMANOVA) between SERT^−/−^ and SERT^+/+^ mice and trended (*p* = 0.05, PERMANOVA) towards a difference between fecal and cecal samples as measured by Jensen-Shannon divergence (Fig. [1C](#Fig1){ref-type="fig"}). There were no significant differences between the two batches of mice. Notably, the difference between SERT^−/−^ and SERT^+/+^ mice accounts for 9% of variance in microbial abundances (r^2^ = 0.09, PERMANOVA), indicating the differences between the SERT^−/−^ and SERT^+/+^ mice are significant but not large. Jensen-Shannon Divergence was compared between and within strains in fecal and cecal samples (Fig. [1D](#Fig1){ref-type="fig"}). SERT^−/−^ had lower with-in group variance as compared to SERT^+/+^ mice, indicating that SERT deficiency has a selective pressure on the microbiota.Figure 1SERT deficiency alters bacterial diversity. (**A**) Rarefaction curves between SERT^+/+^ and SERT^−/−^ cecal and fecal samples. (**B**) Box-plot of α-diversity (Shannon index) between SERT^+/+^ and SERT^−/−^ cecal and fecal samples. Differential testing by two-way ANOVA, *p* \< 0.05 was considered significant. (**C**) PCoA, displaying the first two principle components, of β-diversity (Jensen-Shannon divergence) between SERT^+/+^ and SERT^−/−^ cecal and fecal samples. Differential testing PERMANOVA using *adonis*, *p* \< 0.05 was considered significant. (**D**) Jensen-Shannon Divergence between and within strains in fecal and cecal samples.

SERT deficiency changes the abundance of Firmicutes, Actinobacteria, and Verrucomicrobia species {#Sec4}
------------------------------------------------------------------------------------------------

To determine if SERT deficiency alters bacterial abundance, the top five most abundant bacterial phyla in SERT^−/−^ and SERT^+/+^ mice were compared. The top five phyla accounted for greater than 90% of all reads in every sample (Fig. [2A](#Fig2){ref-type="fig"}, Table [E2](#MOESM1){ref-type="media"}). There was a significant (*p* \< 0.05, Two-way ANOVA) increase in the abundance of Firmicutes in SERT^−/−^ compared to SERT^+/+^ mice (Fig. [2B](#Fig2){ref-type="fig"}). There were decreases (*p* = 0.10 and *p* \< 0.05, Two-way ANOVA) in Actinobacteria and Verrucomicrobia abundances in SERT^−/−^ mice compared to SERT^+/+^ (Fig. [2B](#Fig2){ref-type="fig"}). There was a trend (*p* = 0.06, Two-way ANOVA) towards lower Firmicutes in fecal isolates compared to cecal isolates, whereas there was no difference in the abundances of Actinobacteria or Verrucomicrobia between cecal and fecal isolates. To identify changes in species abundances across multiple sampling sites between SERT^+/+^ and SERT^−/−^ mice bacterial counts were assessed as function of two different models. In the full model, bacterial counts were modeled as a function of the strain of mice (SERT^+/+^ vs. SERT^−/−^), the source of sampling (cecal vs. fecal), the batch that the samples were sequenced, and the interaction between strain and sampling. In the reduced model, bacterial counts were modeled only as a function of the source of sampling and the batch that the samples were sequenced. 34 species of bacteria were identified whose variance was significantly estimated (Benjamini-Hochberg corrected *p* \< 0.1, Likelihood Ratio Test *DESeq. 2*) by the full model compared to the reduced model (Table [E3](#MOESM2){ref-type="media"}). In agreement with results seen at the phyla level of taxonomy 22 of 34 differentially abundant species were of the phylum, Firmicutes, Actinobacteria, and Verrucomicrobia (Table [E4](#MOESM3){ref-type="media"}). Notably, of the species that belonged to other phyla, 10 were Proteobacteria, 1 was Bacteroidetes, and 1 was Deinococcus-Thermus, all of which had very low abundances (median relative abundance \<0.05%). Using these 34 differentially abundant bacteria, SERT^+/+^ and SERT^−/−^ mice could be significantly discriminated (*p* = 0.001 accuracy = 80%, Fisher's Exact test) from each other using hierarchal clustering (Fig. [3A](#Fig3){ref-type="fig"}). There were several notable trends with respect to differences between SERT^−/−^ and SERT^+/+^ mice. First, SERT^−/−^ mice displayed higher abundances of species that can be categorized as Bacilli, including those of genera Lactobacillus, Streptococcus, Enterococcus, and Listeria. Of these Bacilli species, *Lactobacillus ruminis* was the most abundant. Secondly, SERT^−/−^ mice have significantly lower abundances of *Bifidobacterium* species and *Akkermansia muciniphilia* compared to SERT^+/+^ mice (Fig. [3B](#Fig3){ref-type="fig"}). These results confirm the phylum level observations.Figure 2SERT deficiency alters bacterial abundance at the phyla level. (**A**) Bar plot of average abundance of top five phyla in SERT^+/+^ and SERT^−/−^ cecal and fecal samples. (**B**) Box-plots of Firmicutes, Actinobacteria, and Verrucomicrobia, whose abundances differed between SERT^+/+^ and SERT^−/−^ mice. Differential testing by two-way ANOVA, *p* \< 0.05 was considered significant.Figure 3SERT^−/−^ mice have altered abundance of *Akkermansia*, Bacilli, and *Bifidobacterium* species. (**A**) Heat map of differentially abundant species between SERT^+/+^ and SERT^−/−^ mice. Bacterial relative abundances were log~10~ transformed for visualization. Differential abundance testing was performed by likelihood ratio test (*DESeq. 2*), adjusted *p* \< 0.1 (Benjamini-Hochberg multiple testing correction) was considered significant. Hierarchal clustering was used to separate samples based on abundances of differentially abundant bacteria. Fisher's exact test was used to determine if SERT^+/+^ and SERT^−/−^ mice were significantly discriminated by hierarchal clustering, *p* \< 0.05 was considered significant. (**B**) Log2 fold changes of species that were differentially abundant.

Bacterial community structure is altered in SERT deficient mice {#Sec5}
---------------------------------------------------------------

In the mammalian intestine, bacteria co-exist with one another and are highly dependent on other species to provide specific nutrients required for growth. Due to this, many bacteria exist in specific communities or ecological niches within the gut. To assess community structure differences between SERT^−/−^ and SERT^+/+^ mice, co-occurrence networks were generated for highly significant (*p* \< 0.001, *SPARCC*) bacterial species-species co-occurrences (Fig. [4A,B](#Fig4){ref-type="fig"}). The networks for SERT^−/−^ and SERT^+/+^ were highly dissimilar. SERT^−/−^ mice co-occurrence network displayed a higher network diameter, clustering coefficient, and had a lower scale-free network fit compared to SERT^+/+^ mice (Fig. [4C--E](#Fig4){ref-type="fig"}). Additionally, of the 2485 total co-occurrences observed only 207 (\<1%) were observed between both SERT^−/−^ and SERT^+/+^ co-occurrence networks (Fig. [4F](#Fig4){ref-type="fig"}). These overlapping co-occurrences between the SERT^−/−^ and SERT^+/+^ revealed three distinct communities dominated by specific phylogenies: Bacteroidetes, Clostridia, and Bacilli dominant communities (Fig. [S1A](#MOESM1){ref-type="media"}). Notably, the interactions between these communities were dissimilar between SERT^−/−^ and SERT^+/+^. In SERT^+/+^ mice many Bacteroidetes species co-occur with Bacilli species, whereas in SERT^−/−^ there is no co-occurrence between Bacteroidetes species and Bacilli species (Fig. [S1B,C](#MOESM1){ref-type="media"}). In addition to these conserved communities, it was observed that a community of Bifidobacterium species co-occurred in SERT^+/+^ but was absent SERT^−/−^ (Fig. [S1D,E](#MOESM1){ref-type="media"}). Changes in community structure could be due to loss or gain of hub species. To assess for hub species in each network, we defined hubs as species with \>90^th^ percentile of degree and closeness centrality of their network (Fig. [S2](#MOESM1){ref-type="media"}). Notably, several *Firmicutes* species were identified as hubs in both networks, whereas *Akkermansia muciniphilia*, several *Proteobacteria*, and *Bacteroidetes* species where only identified as hubs in SERT^+/+^ mice. *Akkermansia muciniphilia* was decreased in SERT^−/−^ mice indicating that loss of a hub species is associated with changes in the community structure of the microbiome in SERT^−/−^ mice.Figure 4SERT^−/−^ mice have altered bacterial community structure. Bacterial-bacterial co-occurrence networks were generated for significant co-occurrences in (**A**) SERT^+/+^ and (**B**) SERT^−/−^ mice. Bacteria are colored by class and sized is by betweeness centrality. Significant edge testing was determined using SPARCC with 500 bootstraps, *p* \< 0.001 was considered significant. Differences in (**C**) network diameter, (**D**) clustering coefficient, (**E**) scale-free fit, and (**F**) overlap in edges display differential network structure.

Differentially abundant bacteria are associated with gene expression changes observed in SERT deficient mice {#Sec6}
------------------------------------------------------------------------------------------------------------

SERT^−/−^ mice have been shown to have differential gene expression changes compared to SERT^+/+^ mice (GEO accession GSE93534). To test if changes in the microbiome composition were associated with gene expression changes in SERT^−/−^ mice, the 34 differentially abundant bacteria were correlated with the ΔCt of *Hmgcs2, Cyp1a1, Cldn8*, and *Acot1* in the ileal mucosa and *Hmgcr* in the liver (Fig. [5](#Fig5){ref-type="fig"}). It was observed that *Bifidobacterium* species and *Bacilli* species had many significant associations with *Hmgcs2*, *Acot1*, and *Hmgcr*. Neither group of bacteria was highly associated with the expression of *Cyp1a1* or *Cldn8*. This indicates that changes in lipid metabolism that are observed in SERT^−/−^ are associated with changes in the composition of the microbiome.Figure 5Differentially abundant bacteria significantly correlate with gene expression of HMGCS2 and HMGCR. Heatmap of Pearson's correlations between *HMGCS2* and *HMGCR* gene expression (ΔCt) and the abundance (log~10~ relative abundance) of differentially abundant bacteria.

SERT deficiency is associated with changes in the abundance of genes involved in fatty acid metabolism {#Sec7}
------------------------------------------------------------------------------------------------------

To assess if there were any changes in the abundance of functional categories of genes, SEED and KEGG pathway counts were assessed. Broad categorizations of metabolic pathways showed no differences (Fig. [6A](#Fig6){ref-type="fig"}). To test if the composition of functions was significantly different, we compared level 3 SEED pathways using PCoA (Fig. [6B](#Fig6){ref-type="fig"}). Functional compositions were significantly different (PERMANOVA, *p* \< 0.05) between strain of mice (SERT^+/+^ vs. SERT^−/−^), the source of sampling (cecal vs. fecal), but not between batch. In the full model, SEED or KEGG pathways were modeled as a function of the strain of mice (SERT^+/+^ vs. SERT^−/−^), the source of sampling (cecal vs. fecal), the batch that the samples were sequenced, and the interaction between strain and sampling. In the reduced model, SEED or KEGG pathway counts were modeled only as a function of the source of sampling and the batch that the samples were sequenced. Using SEED level 3 classifications, we found three pathways that were significantly enriched (Benjamini-Hochberg corrected *p* \< 0.1, Likelihood Ratio Test *DESeq. 2*) in SERT^+/+^ in both fecal and cecal samples: l-ascorbate utilization, trehalose uptake and utilization, and phage integration and excision (Table [E5](#MOESM4){ref-type="media"}). We identified a single KEGG pathway, biosynthesis of unsaturated fatty acids \[ko01040\], whose variance was significantly estimated (Benjamini-Hochberg corrected *p* \< 0.1, Likelihood Ratio Test *DESeq. 2*) by the full model compared to the reduced model (Fig. [7A](#Fig7){ref-type="fig"}, Table [E6](#MOESM5){ref-type="media"}). This pathway was significantly more abundant in the SERT^+/+^ mice compared to SERT^−/−^ mice (Fig. [7A](#Fig7){ref-type="fig"}). This pathway also significantly associated (*p* \< 0.05, Pearson's correlation) with the expression of both *Hmgcs2* and *Hmgcr* (Fig. [7B](#Fig7){ref-type="fig"}). This pathway did not associate with *Acot1, Cyp1a1*, or *Cldn8* (data not shown). The main contributors to these pathways were notably differentially abundant bacteria, *Firmicutes*, *Bifidobacterium*, and *Akkermansia* (Fig. [8](#Fig8){ref-type="fig"}). This indicates that loss and gains of species are not completely functionally redundant and result in changes in functional capabilities of the microbiome.Figure 6SERT^−/−^ mice are enriched for pathways involved in sugar and l-ascorbate metabolism. (**A**) Bar plot of average abundance of top Level 1 SEED pathways (\>2% abundance) in SERT^+/+^ and SERT^−/−^ cecal and fecal samples. (**B**) PCoA of Level 3 SEED pathways, displaying the first two principle components, Jensen-Shannon divergence between SERT^+/+^ and SERT^−/−^ cecal and fecal samples. Differential testing PERMANOVA using *adonis*, *p* \< 0.05. (**C**) Log2 fold changes of pathways that differentially abundant. Differential abundance testing was performed by likelihood ratio test (*DESeq. 2*), adjusted *p* \< 0.1 (Benjamini-Hochberg multiple testing correction) was considered significant.Figure 7Abundance of genes involved in the biosynthesis of unsaturated fatty acids are depleted in SERT^−/−^ mice and are associated with the expression of HMGCS2 and HMGCR. (**A**) Abundance (log~10~ normalized count) of the KEGG pathway, biosynthesis of unsaturated fatty acids \[ko01040\]. Differential abundance testing was performed by likelihood ratio test (*DESeq. 2*), adjusted *p* \< 0.1 (Benjamini-Hochberg multiple testing correction) was considered significant. (**B**) Linear regression between gene expression of HMGCS2 (ΔCt) and abundance of the KEGG pathway, biosynthesis of unsaturated fatty acids \[ko01040\], *p* \< 0.05 was considered significant. Points are colored by SERT^+/+^ and SERT^−/−^ mice.Figure 8Differentially abundant bacteria are sources for differentially abundant functional pathways. Two representative pathways are shown as stacked bar graphs, where the contribution of each genus to the total reads assigned to a pathway is displayed.

Discussion {#Sec8}
==========

The gut microbiome plays an important role in the pathogenesis of various health disorders^[@CR32]--[@CR36]^. In the current study, the fecal and cecal microbiomes of adult SERT^+/+^ and SERT^−/−^ mice were sequenced and analyzed under basal conditions. Fecal microbiota likely represent a mixture of indigenous and transient microbes from the entire GI tract^[@CR37]^. We demonstrate that the loss of SERT leads to alterations in gut microbial composition, which is consistent with the metabolic syndrome observed in these mice. Interestingly, changes in metabolic capabilities of the gut microbiome were associated with changes in host gene expression of enzymes involved in lipid metabolism in SERT^−/−^ mice. Collectively, our study confirms that the loss of SERT in mice is associated with gut microbial dysbiosis and this dysbiosis correlates with metabolic alterations within the host.

In our study, β-diversity showed a significant difference between SERT^+/+^ and SERT^−/−^ mice. SERT^−/−^ mice had less variance in gut microbial compositions, indicating that SERT deficiency is exerting a selective pressure on the gut microbiome. On the taxonomic level, the SERT^−/−^ mice had a significant increase in Firmicutes as compared to SERT^+/+^ mice. Previous studies have shown that the abundance of Firmicutes is associated with obesity in mice^[@CR38],[@CR39]^. While the exact mechanism for this association is not certain, it is thought that Firmicutes have a high capacity to hydrolyze non-digestible polysaccharides into molecules which are absorbed by the host and stored as excess calories^[@CR40]^. We observed increased abundance of genes involved in trehalose, a disaccharide, uptake and utilization in SERT^−/−^ mice. Interestingly, it was recently shown that epidemic ribotypes of *Clostridium difficile* have acquired mutations in trehalose metabolizing enzymes which increases their virulence^[@CR41]^. Studies in zebrafish have shown that higher abundance of Firmicutes leads to increase in the number and sizes of the lipid droplets thus promoting fatty acid absorption in the extra intestinal tissues^[@CR42]^. Among the differentially abundant Firmincutes, *Lactobacillus ruminis* was the most abundant. *L. ruminis* is a lactic acid producing bacteria that is known to exhibit commensal relationship with its host^[@CR43]^. Interestingly, the abundance of *L. ruminis* has been observed at higher abundance in overweight and obese patients^[@CR44]^.

Actinobacteria and Verrucomicrobia, as well as *Bifidobacteria*, showed decreased abundances in SERT^−/−^ mice as compared to SERT^+/+^ mice. *Bifidobacteria*, are one of the abundant probiotic species present in the mammalian gut^[@CR45]^. Previous studies in rats have shown anti-obesity and lipid lowering effects of these bacteria when supplemented along with a high-fat diet and an inverse correlation with BMI^[@CR46],[@CR47]^. Thus, low abundance of *Bifidobacteria* species including *B. bifidum*, *B. animalis*, and *B. breve* could be associated with the metabolic disturbances observed in SERT^−/−^ mice. *Akkermansia muciniphila* of the phylum Verrucomicrobia was significantly less abundant in SERT^−/−^ mice as compared to SERT^+/+^ mice. Many animal models of metabolic syndrome had lower levels of *A. muciniphila*^[@CR48]^. Clinical studies show an inverse correlation of *A. muciniphila* to metabolic parameters including fasting glucose levels, waist-to-hip ratio, and subcutaneous adipocyte diameter^[@CR48],[@CR49]^. Further, interventional studies in mouse models have provided evidence of a direct role of *A. muciniphila* in reversing metabolic disorders^[@CR50],[@CR51]^.

Microarray analysis of the small intestinal mucosa revealed remarkable differences in gene expression in SERT^−/−^ mice as compared to SERT^+/+^ mice^[@CR31]^. Of interest, several genes involved in lipid metabolism were up-regulated including *Hmgcs2*, *Bdh2*, *Acot1*, and *Acot2*. *Hmgcr* was found to be down-regulated in the liver of SERT^−/−^ mice, as expected due to the hepatic steatosis that develops in SERT^−/−^ mice^[@CR22]^. Interestingly, gut microbiota can have profound systemic effects^[@CR52]^. Notably, in our studies both the cecal and fecal microbiota changes correlated with gene expression changes related to lipid metabolism not only in ileum but also in the liver. For example, our analysis showed that among the 34 differentially abundant bacteria, the expression of intestinal *Hmgcs2*, *Acot1* and liver *Hmgcr* associated significantly with the abundance of several *Bifidobacterium* species and *Bacilli* species.

The gut microbial community performs a range of useful functions for the host, including digesting substrates inaccessible to host enzymes, educating the immune system, and repressing the growth of harmful microorganisms. We identified several pathways that are associated with SERT deficiency. One pathway, biosynthesis of unsaturated fatty acids \[ko01040\], was significantly less abundant in SERT^−/−^ mice as compared to SERT^+/+^. The most abundant gene in this pathway was *tesB*, which encodes a bacterial acyl-CoA thioesterase (*Acot*). *tesB* was nearly absent in SERT^−/−^ mice, in contrast to the dramatic upregulation of host *Acot* enzymes which catalyze the same biochemical reactions. This implies that the host and microbiome share redundant functions. From our analysis, it is not clear whether the host selects for microbial function or vice versa.

The community structure of the microbiome was significantly altered in SERT^−/−^ mice as compared to SERT^+/+^ mice. The SERT^−/−^ microbiome consisted of disconnected sub-networks, in contrast to SERT^+/+^ where microbial networks were more cohesive. This indicates loss of interaction between bacteria in SERT^−/−^. In addition, the number of overlapping co-occurrences seen in SERT^+/+^ and SERT^−/−^ were drastically decreased. There was also a loss of several hub species, those species which have large influence over the network, in SERT^−/−^ mice which also had decreased abundance in SERT^−/−^, *A. muciniphila* and *Desulfovibrio*. It is possible loss a hub species, such as *A. muciniphila* and *Desulfovibrio*, could change the abundance of many other species due to their large influence on the network. SERT deficiency could therefore, dramatically alter the stability of bacterial communities, thus disturbing bacterial homeostasis.

There are a few limitations to our study. First, it is not clear whether changes in metabolic capacity of the microbiome are causing changes in host metabolic pathways in SERT^−/−^ mice, or vice-versa. Our study design did not allow for examination of temporal relationships which could allow for casual determinations. A recent study has characterized the fecal microbiome in SERT^+/+^ and SERT^−/−^ rats, and the compounding effect of genotype and maternal separation^[@CR53]^. Similar to SERT^−/−^ mice, SERT^−/−^ rats also exhibit a metabolic syndrome-like phenotype which has been characterized at 12 weeks of age^[@CR54]^. However, the rat microbiome study was performed at 3 weeks of age, therefore any microbiome changes related to metabolic syndrome may be absent. Nonetheless, there were similarities to our current study (e.g., both the rat study and our study showed an increase in the prevalence of Firmicutes and reduced *Desulfovibrio* spp). In contrast to our findings, there was an increase in Fusobacteria in the rat study. They also did not report any changes in bacteria that were drastically altered in our study such as *A. muciniphila* or *Bifidobacteria*. In mice, previous studies have shown that 3-month old SERT^−/−^ mice do not exhibit an increase in body weight and body fat content, although they did manifest glucose and insulin intolerance^[@CR22]^. These findings suggested that the metabolic deficits developed prior to a significant increase in the adiposity (around 6 months) in SERT^−/−^ mice via estrogen dependent pathways. Future studies should focus on the temporal analysis of microbiota both in SERT^−/−^ and SERT over-expressing mice to provide insights into age dependent effects of SERT on obesity.

Collectively, our data indicates that SERT plays a vital role in maintaining homeostasis of the gut microbiota, and that its deficiency leads to loss of bacterial niches and altered microbial metabolic capabilities. This is clinically relevant, as selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed for treatment of depression and other psychiatric disorders. Additionally, SERT expression is decreased in several pathophysiological conditions, including inflammatory bowel diseases and irritable bowel syndrome. Thus, understanding the contribution of SERT to gut microbial homeostasis is crucial. Overall, the findings of the current study establish a strong foundation for understanding the involvement of the intestinal microbiome in the pleotropic consequences of SERT deficiency.

Methods {#Sec9}
=======

Mice {#Sec10}
----

SERT^+/+^ and SERT^−/−^ mice of C57BL/6 background (purchased from Jackson Laboratory) were bred in-house at the Jesse Brown Veterans Affairs Medical Center animal facility. Animals were housed in autoclaved polypropylene cages with corncob bedding under a specific pathogen-free environment under a 12 h light/dark cycle. Genotyping was carried out after tail clipping on 4 weeks old mice. The mice were co-housed by genotype until 11--12 weeks of age when fecal and cecum stool samples were collected. Two separate batches of mice consisting of both males and females were used for the current study. All animal studies were performed in accordance with institutional guidelines and regulations and as approved by the Animal Care Committees of the University of Illinois at Chicago and the Jesse Brown Veterans Affairs Medical Center.

Microbial Sampling and DNA Isolation {#Sec11}
------------------------------------

Mice were placed on wire bottom cages for 24 h to collect fecal pellets and stored at −80 °C. Following this, mice were anesthetized and dissected. Fresh cecal content was collected from the gut and placed into autoclaved microcentrifuge tubes, and stored at −80 °C till further use. One or two fecal pellets, and 25--50 mg of cecal content was used for metagenomic DNA isolation using PowerSoil DNA isolation kit (Catalogue \# 12888-100, MO BIO Laboratories, Inc) using the method as described previously^[@CR55]^. The quality and quantity of the DNA was accessed using a spectrophotometer (NanoPhotometer Pearl, Denville Scientific, Inc), agarose gel electrophoresis, and fluorometer (Qubit® dsDNA High Sensitivity and dsDNA Broad Range assay, Life Technologies Corporation).

Metagenomic Library Preparation and Metagenomic Shotgun Sequencing {#Sec12}
------------------------------------------------------------------

To prepare Illumina sequencing compatible libraries for shotgun sequencing, 500 ng metagenomic DNA was mechanically sheared to generate 450--600 bp fragments using a Covaris S220 instrument (Covaris, Inc). Fragmented metagenomic DNA was end-repaired and 3′-adenylated, ligated with Illumina adapters, and PCR enriched with Illumina sequencing indexes (barcodes) using the NEBNext Ultra DNA library prep kit for Illumina (Catalogue \# E7370L,New England BioLabs Inc). The quality and quantity of all the DNA libraries were analyzed with an Agilent DNA 1000 Kit on the 2100 Bioanalyzer Instrument and Qubit. DNA libraries were pooled in equimolar concentration and were sequenced following manufacturer's protocol by multiplexing on Illumina MiSeq using the v3-600 kit for 301 paired-end read length and included an additional 12 cycles for the index. The average sequencing depth was approximately 3 million paired end reads per sample or 1.03 Gbp per sample.

Taxonomic and Functional Profiling {#Sec13}
----------------------------------

The produced metagenomic sequencing reads were processed with our custom data analysis pipeline "WE VOTE" that is hosted on the UIC supercomputer "Extreme". First, the sequences were quality controlled by filtering out all low-quality reads (\<25 on Phred quality score), short reads (\<100 bp), or any mouse reads. High-quality microbial reads were then assembled into longer contigs using MetaVelvet^[@CR56]^. For each sample, the microbial taxonomic profile was constructed using WEVOTE^[@CR57]^. Since WEVOTE is an ensemble classifier, we used Kraken, Clark, and BLASTN as base classifiers for WEVOTE^[@CR58],[@CR59]^. Using this approach, we were able to classify an average of 230,610 reads per sample at the species level. To identify specific functions in the microbiome, reads were upload to MG-RAST and annotated using the KEGG and SEED databases with default parameter settings^[@CR60]^. Functions were assessed at the pathway level 3.

RNA Extraction and RT-qPCR {#Sec14}
--------------------------

Total RNA was extracted from mouse ileal mucosal scrapings or liver using Qiagen RNeasy kits. RNA was reverse transcribed and amplified using a Brilliant SYBR Green qRT-PCR Master Mix kit (Stratagene). The gene-specific primer sequences are listed in Supplementary Table [E1](#MOESM1){ref-type="media"}. The relative mRNA levels were normalized to *Gapdh* mRNA levels using the ΔΔCt method.

Statistics {#Sec15}
----------

All statistical analyses were performed in *R* (Version 3.3) unless otherwise specified. Diversity metrics, Shannon Index and Jensen-Shannon divergence, were calculated using *phyloseq*.^[@CR61]^. Shannon index was compared by two-way ANOVA. Jensen-Shannon divergence was compared by permutational ANOVA (PERMANOVA) modeling for mouse genotype, source, and batch of metagenome. For phylum level analysis, species counts were agglomerated and assess using two-way ANOVA. *P* \< 0.05 was considered statistically significant. Differentially abundant species and KEGG pathways were identified using likelihood ratio test in DESeq. 2^[@CR62]^. Counts were modeled as a function of mouse genotype (SERT^+/+^ vs. SERT^−/−^), source (Fecal vs. Cecal), the interaction between source and genotype, and batch in the full model and source and batch in the reduced model. Benajmini-Hochberg corrected for multiple testing *P* \< 0.1 was considered statistically significant. To test for associations between species abundance and gene expression, normalized counts (DESeq. 2 median sum scaling) of species were correlated with ΔCt of genes of interest. Pearson's correlation coefficient was used to assess statistical significance, *P* \< 0.05 was considered statistically significant. ΔCt represents reduced gene expression therefore correlation coefficient is opposite of the effect. Co-occurrence networks were constructed using *SPARCC* with bootstrapping (*B* = 500) in the *spieceasi* package^[@CR63]^. Edges with *P* \< 0.001 and positive correlations were considered significant edges (ie significant co-occurrences). Network graphs and statistics were plotted and calculated in *Cytoscape*^[@CR64]^.

Study Approval {#Sec16}
--------------

Animal studies were approved by the Animal Care Committees of the University of Illinois at Chicago and the Jesse Brown Veterans Affairs Medical Center. All studies were conducted in accordance with institutional guidelines and regulations at the University of Illinois at Chicago and the Jesse Brown Veterans Affairs Medical Center.
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